Inc.

Ecolab Investment in Renewable Energy to Source 100% of Company’s European Power Requirements

Retrieved on: 
Monday, April 4, 2022

The Mrknsskogen wind farm, developed by renewable energy investment and asset management firm Low Carbon, will produce approximately 100GWh of renewable energy each year, or enough energy to power more than 29,000 homes.

Key Points: 
  • The Mrknsskogen wind farm, developed by renewable energy investment and asset management firm Low Carbon, will produce approximately 100GWh of renewable energy each year, or enough energy to power more than 29,000 homes.
  • www.ecolab.com
    Low Carbon is a leading renewable energy investment and asset management platform committed to the development and operation of renewable energy at scale.
  • Low Carbon invests into both renewable energy developers and projects across a range of renewable energy technologies including solar PV, wind, energy storage, waste-to-energy and energy efficiency.
  • With a significant international renewable energy pipeline in development, Low Carbon are well-positioned to capitalise on opportunities as the need for renewable energy and energy security increases.

AdCellerant Announces Rebrand to a Tech-First Agency

Retrieved on: 
Saturday, April 2, 2022

DENVER , April 1, 2022 /PRNewswire/ -- AdCellerant, an award-winning tech-enabled Services Company focused on bringing Madison Avenue-level digital marketing solutions to Main Street Businesses, announced today their rebranding efforts. Born in 2013, AdCellerant has become one of the fastest-growing companies according to Deloitte Technology and Inc Magazine 2021 rankings.

Key Points: 
  • Born in 2013, AdCellerant has become one of the fastest-growing companies according to Deloitte Technology and Inc Magazine 2021 rankings.
  • In a note from the executive team, the rebrand comes from AdCellerant's evolution from a service company to a technology company.
  • "With invested time, resources, and capital to rebuild Ui.Marketing-the company's sales enablement, order automation, order management, and reporting platform," said Brock Berry, CEO, and Co-Founder of AdCellerant.
  • The purpose of the AdCellerant rebrand was to show AdCellerant's efforts to become a tech-forward, and innovative company while driving revenue growth for the Partners they work with.

Wayne Savings Bancshares, Inc. Declares Quarterly Dividend

Retrieved on: 
Thursday, March 31, 2022

WOOSTER, Ohio, March 31, 2022 (GLOBE NEWSWIRE) -- Wayne Savings Bancshares, Inc. (OTCQX:WAYN), (the Company), the holding company parent of Wayne Savings Community Bank (the Bank), has declared a cash dividend increase of $0.02 to $0.23 per share of the Companys common stock for the quarter ending March 31, 2022.

Key Points: 
  • WOOSTER, Ohio, March 31, 2022 (GLOBE NEWSWIRE) -- Wayne Savings Bancshares, Inc. (OTCQX:WAYN), (the Company), the holding company parent of Wayne Savings Community Bank (the Bank), has declared a cash dividend increase of $0.02 to $0.23 per share of the Companys common stock for the quarter ending March 31, 2022.
  • The quarterly cash dividend will be paid on May 4, 2022 to stockholders of record as of April 20, 2022.
  • Established in 1899, Wayne Savings Community Bank, the wholly owned subsidiary of Wayne Savings Bancshares, Inc., has twelve full-service banking locations in the communities of Wooster, Ashland, Millersburg, Rittman, Lodi, North Canton, Creston, Fredericksburg and Washingtonville, Ohio.
  • At December 31, 2021, Wayne Savings Bancshares, Inc. reported total assets of $636.0 million, deposits of $540.5 million, and stockholders equity of $53.6 million, or 8.4% of total assets.

Triage Staffing Expands Omaha HQ with New 100,000 Square Foot Building

Retrieved on: 
Tuesday, March 29, 2022

OMAHA, NEB., March 29, 2022 (GLOBE NEWSWIRE) -- Triage Staffing , a leader in the healthcare staffing industry based in Omaha, recently finalized the location of its new corporate headquarters.

Key Points: 
  • OMAHA, NEB., March 29, 2022 (GLOBE NEWSWIRE) -- Triage Staffing , a leader in the healthcare staffing industry based in Omaha, recently finalized the location of its new corporate headquarters.
  • The building, located at 13609 California Street, more than triples Triages Omaha office space with 100,000 plus square feet.
  • The new building signifies the companys commitment to growth and creates an opportunity for them to triple their Omaha workforce.
  • Renovations on the new Triage HQ begin in August 2022 and Triage expects to be fully moved in by February 2023.

Cybin Announces Additional Adelia Milestone Achievement

Retrieved on: 
Friday, April 1, 2022

Cybin Inc. ( NEO:CYBN ) (NYSE AMERICAN:CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics, is pleased to announce that Adelia Therapeutics Inc. (Adelia), a wholly-controlled subsidiary of Cybin, has achieved the milestone identified as Year 1, Q2 (iv) as contemplated by the terms of a contribution agreement dated December 4, 2020 (the Transaction Agreement) among Cybin, Cybin Corp., Cybin US Holdings Inc. (the Acquiror), a wholly-controlled subsidiary of Cybin, and all of the previous shareholders of Adelia (the Adelia Shareholders).

Key Points: 
  • Cybin Inc. ( NEO:CYBN ) (NYSE AMERICAN:CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics, is pleased to announce that Adelia Therapeutics Inc. (Adelia), a wholly-controlled subsidiary of Cybin, has achieved the milestone identified as Year 1, Q2 (iv) as contemplated by the terms of a contribution agreement dated December 4, 2020 (the Transaction Agreement) among Cybin, Cybin Corp., Cybin US Holdings Inc. (the Acquiror), a wholly-controlled subsidiary of Cybin, and all of the previous shareholders of Adelia (the Adelia Shareholders).
  • The Class B Shares issued by the Acquiror to the Adelia Shareholders are exchangeable for common shares in the capital of Cybin (the Cybin Shares) on a 10 Cybin Shares for 1 Class B Share basis, at the option of the holder thereof, subject to customary adjustments.
  • Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, United Kingdom and Ireland.
  • Any references to quality, consistency, efficacy and safety of potential products do not imply that Cybin verified such in clinical trials or that Cybin will complete such trials.

Kiromic Biopharma Announces Filing of Form 12b-25

Retrieved on: 
Friday, April 1, 2022

The Company expects to file its 2021 Form 10-K during the 15-calendar day extension period.

Key Points: 
  • The Company expects to file its 2021 Form 10-K during the 15-calendar day extension period.
  • Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND artificial intelligence (AI) platform to discover and develop cell and gene therapies with a therapeutic focus on immuno-oncology and other diseases.
  • Kiromic is in the process of developing a multi-indication allogeneic CAR-T cell therapy that exploits the natural potency of Gamma Delta T-cells to target solid cancers.
  • From its heritage as a cancer vaccine development company, Kiromic is focused on discovering, developing, and commercializing novel immuno-oncology applications through its robust product pipeline.

Deborah Besemer to Retire as Chairman of Brightcove’s Board of Directors

Retrieved on: 
Friday, April 1, 2022

Brightcove Inc. (Nasdaq: BCOV), the leading intelligent video streaming, monetization, and communications platform, today announced that Deborah Besemer, the Chairman of Brightcoves board of directors, and a board member since 2008, will retire from the board at the end of her current term at the Companys 2022 Annual Meeting.

Key Points: 
  • Brightcove Inc. (Nasdaq: BCOV), the leading intelligent video streaming, monetization, and communications platform, today announced that Deborah Besemer, the Chairman of Brightcoves board of directors, and a board member since 2008, will retire from the board at the end of her current term at the Companys 2022 Annual Meeting.
  • The Company has appointed Diane Hessan, who has served as a Brightcove board member since 2017, as its new Chairman, effective as of the Annual Meeting.
  • It has been a privilege to serve as a member of Brightcoves board for the past 14 years and help the company grow from a small start-up to the global leader in video for business and a successful public company, said Deborah Besemer, Brightcoves outgoing board chairman.
  • I am incredibly confident in the future of Brightcove and am thrilled that Diane will be taking over as board chairman to help lead the company through its next phase of growth.

Workiva Inc. Strengthens its Transparent Reporting Leadership Position with the Acquisition of ParsePort

Retrieved on: 
Friday, April 1, 2022

Workiva Inc. (NYSE:WK), the company powering transparent reporting for a better world, announced today that it has acquired Denmark-based ParsePort .

Key Points: 
  • Workiva Inc. (NYSE:WK), the company powering transparent reporting for a better world, announced today that it has acquired Denmark-based ParsePort .
  • View the full release here: https://www.businesswire.com/news/home/20220401005082/en/
    Workiva Inc. Strengthens its Transparent Reporting Leadership Position with the Acquisition of ParsePort.
  • We are pleased to welcome the ParsePort team and their in-depth market and technology knowledge as we power transparent reporting for a better world.
  • Aligning ParsePort with Workiva creates an incredible opportunity to set a new standard in digital reporting, said Eriksen.

Zymeworks Announces Participation in Upcoming Investor Conferences

Retrieved on: 
Friday, April 1, 2022

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, today announced that management will participate in upcoming investor conferences:

Key Points: 
  • Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, today announced that management will participate in upcoming investor conferences:
    Wells Fargo 2022 Biotech Forum.
  • Zymeworks will participate in one-on-one meetings on April 12th in Palm Beach Gardens, FL.
  • Zymeworks will participate in one-on-one meetings and will present on May 2nd at 2:00 p.m.
  • Zymeworks suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates.

Volta Inc. Provides Business Update

Retrieved on: 
Friday, April 1, 2022

Furthermore, the Company expects first quarter 2022 revenues to range from $8 million to $8.5 million.

Key Points: 
  • Furthermore, the Company expects first quarter 2022 revenues to range from $8 million to $8.5 million.
  • Volta expects 2022 revenue to be greater in the second half of the year, as a reflection of the growing scale of our network and accompanying seasonal media revenue patterns.
  • Volta Inc. (NYSE: VLTA) is a leading global EV charging network, powering vehicles and commerce.
  • Any forward-looking statements speak only as of the date on which they are made, and Volta undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.